140 likes | 344 Views
dm+d Implementation &. Andrew Frangleton, Product Development Director. What is the Multilex Drug Data File?. Drug Terminology and attributes Products, packs prices, re-imbursement information etc Clinical Decisions Support Drug-Drug Interactions Allergy Check Contra Indications etc
E N D
dm+d Implementation& Andrew Frangleton, Product Development Director
What is the Multilex Drug Data File? • Drug Terminology and attributes • Products, packs prices, re-imbursement information etc • Clinical Decisions Support • Drug-Drug Interactions • Allergy Check • Contra Indications • etc • Referential information • Monographs • Non active decision support information • External Links • BNF, SPc • PIL • etc
Status of Multilex to dm+d Mapping • Overview of FDBE’s internal mapping project • VMP/VMPP maps (70%) • AMP/AMPP maps (48%) • Appliances and VTM – map problems • Issues holding up progress • Similar but different Models • Model Population and stability • V2 Model released April 2004 • VTM not populated • Secondary Care products due later this year
Differences between Multilex & dm+d • Examples • VTM & Product SetMultilex ‘branded’ Product Sets have no equivalence • dm+d has package information in product descriptionseg. injection ampoules, powder sachets • Multilex is more granulareg. Modified Release preparations • Difference in coverage
Working Together • Harmonisation • Striving to reach an agreed way forward • Can improve on the 80% currently not mapped • Involvement of current users is important • Agreement to provide early access to dm+d content by FDBE • Agreement to deliver dm+d as part of the FDBE Product • Agreement to deliver FDBE standard product through national distribution process • FDBE Implementation Team are available to help with dm+d integration
Implementation Services Core services • Technical & functional skills • Comprehensive documentation • Training and consultancy services • Implementation Review – ensuring the quality of final implementation • Post-implementation support services to integrate new features
Delivery of MDDF and dm+d - Today • Current Deliverable Options • ASCII • Link tables provided to allow access to dm+d identifiers • Toolkit • API Functions provided to allow access to dm+d identifiers • Health Warning - link is less than 100%
Future Implementation • Next Toolkit Release will include: • Drug Navigation functions utilising dm+d in conjunction with Multilex • Native instantiation of Drug Object for dm+d codes • Native calls to Decision Support for dm+d codes • SNOMED-CT enabled Decision Support
BT Syntegra – CSA • Working together on Drug Decision Support Service • Will use dm+d to drive product selection • Decision Support will use SNOMED-CT inputs
Summary… • Linking of Multilex to dm+d in progress • Software API’s and ASCII data suitable for linking - available now with limited dataset • Revised API’s due later this year giving a more integrated approach • Customer Implementation Services are availableto help LSP implementations